Automata
Private Company
Total funding raised: $57.5M
Overview
Automata is a private company offering a modular and software-defined lab automation platform called LINQ, which includes hardware (LINQ Bench), workflow design software (LINQ Canvas), and cloud-based orchestration. Its open architecture aims to break down legacy automation silos, allowing labs to integrate diverse instruments, execute parallel workflows, and connect with AI models for advanced data analysis. The company targets the growing demand for flexible, scalable automation in drug discovery, diagnostics, and digital health, with notable partnerships including The Royal Marsden NHS Foundation Trust and the Francis Crick Institute.
Technology Platform
LINQ platform: an open, integrated, AI-ready lab automation ecosystem comprising modular hardware (LINQ Bench), no-code/code workflow design software (LINQ Canvas & Python SDK), and a cloud-based orchestration & analytics layer (LINQ Cloud). It enables software-defined process orchestration, parallel workflow execution, and seamless integration with lab instruments and AI models.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Automata competes in the lab automation market against large, integrated vendors like Thermo Fisher Scientific and Beckman Coulter Life Sciences, as well as specialized robotics firms. Its key differentiation is its open, software-defined, and highly configurable platform, which contrasts with the more closed, proprietary systems historically dominant in the field.